Volume 7, Number 6—December 2001
Dispatch
Legionella-Like and Other Amoebal Pathogens as Agents of Community-Acquired Pneumonia
Thomas J. Marrie*
, Didier Raoult†, Bernard La Scola†, Richard J. Birtles†, Emidio de Carolis‡, and the Canadian Community-Acquired Pneumonia Study Group
, Didier Raoult†, Bernard La Scola†, Richard J. Birtles†, Emidio de Carolis‡, and the Canadian Community-Acquired Pneumonia Study GroupTable 2
Summary of selected characteristics of four patients infected with Legionella-like amoebal pathogen (LLAP)-4
| No. | Age | Sex | Temp | Symptoms | LOS | WBC | Antibiotics | Comments | Antibody titer | Co-pathogens |
|---|---|---|---|---|---|---|---|---|---|---|
| TM37 | 93 | M | 38.3 | nausea, myalgia, shortness of breath, nonproductive cough, chest pain | 8 | 18.2 | erythromycin; cefuroxime | admitted from a nursing home, sustained a non q wave myocardial infarction | IgG 1:400 and 1:400 | None |
| TM11 | 87 | F | 39.0 | nonproductive cough, chills | 11 | 8.7 | erythromycin; cefuroxime | IgG 0 and 1:100 | None | |
| ML13 | 54 | M | 38.4 | abdominal pain, nonproductive cough, myalgia, chest pain | 17 | 2.2 | erythromycin; ceftazidime, ribavirin | bone marrow transplant; required intensive care unit treatment | IgM 25 and 0; IgG 200 and 1:400 | RSV |
| LN 9 |
63 |
M |
36.8 |
shortness of breath, chills |
10 |
20.8 |
erythromycin, cefuroxime |
IgM 1:200 and 1:200 |
Strepto-coccus pneumoniae |
|
M = male; F = female; LOS = length of stay in days; wbc = leukocyte count; antibody titer = first value is from acute-phase sample and second from convalescent-phase sample.
